Expression of biologically active C3a as fusion proteins
- 31 October 1993
- journal article
- Published by Elsevier in Immunology Letters
- Vol. 38 (2) , 153-158
- https://doi.org/10.1016/0165-2478(93)90181-z
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Designing synthetic superagonists of C3a anaphylatoxinBiochemistry, 1991
- Active recombinant C3a of human anaphylatoxin produced in Escherichia coliBiochemical and Biophysical Research Communications, 1991
- Expression cloning of a receptor for C5a anaphylatoxin on differentiated HL-60 cellsBiochemistry, 1991
- The chemotactic receptor for human C5a anaphylatoxinNature, 1991
- Construction and expression of a novel recombinant anaphylatoxin, C5a-N19, as a probe for the human C5a receptorBiochemistry, 1990
- An Escherichia coli vector to express and purify foreign proteins by fusion to and separation from maltose-binding proteinGene, 1988
- Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferaseGene, 1988
- Demonstration of a specific C3a receptor on guinea pig platelets.The Journal of Immunology, 1988
- Anaphylatoxin-mediated regulation of the immune response. I. C3a-mediated suppression of human and murine humoral immune responses.The Journal of Experimental Medicine, 1982
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970